Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-07-19
2005-07-19
Li, Q. Janice (Department: 1632)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S002600, C435S320100, C424S184100, C424S188100, C424S189100, C530S350000
Reexamination Certificate
active
06919318
ABSTRACT:
The immune response to a DNA immunogen in a mammal can be enhanced by administration of a chemokine or a polynucleotide encoding the chemokine. This method can be used, for example, to immunize or vaccinate a mammal against an infectious disease or a tumor.
REFERENCES:
patent: 5846546 (1998-12-01), Hurwitz et al.
patent: 6214540 (2001-04-01), DeVico et al.
patent: 6297048 (2001-10-01), Jolly et al.
patent: 6355247 (2002-03-01), Selby et al.
patent: 6383774 (2002-05-01), Chandrashekar
patent: 6569418 (2003-05-01), Garzino-Demo et al.
patent: WO 94/28916 (1994-12-01), None
patent: WO 96/11279 (1996-04-01), None
patent: WO 96/36366 (1996-11-01), None
patent: WO 97/19696 (1997-06-01), None
patent: WO 98/15286 (1998-04-01), None
patent: WO 99/29728 (1999-06-01), None
Nakano et al. Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode pp. 7101-7109 vol. 71, No. 9.
McCluskie et al. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates pp. 287-300 1999.
Gunn et al. A B-cell-homing chemokine made in lymphoid follicles activities burkitt's lymphoma receptor-1 pp. 799-803 1998.
Nakano et al., Immunization with Plasmid DNA Encoding Hepatitis C Virus . . . , Sep. 1997, Journal of Virology, vol. 71, No. 9, pp. 7101-7109.
Inxhauspe et al., Immune Response Against Hepatistis C Virus Structural Proteins Following Genetic Immunisation, 1998, vol. 92, pp. 163-168.
Lagging et al., Immune Responses to Plasmid DNA Encoding the Heptitis C Virus Core Protein, Sep. 1995, Journal of Virology, vol. 69, No. 9, pp. 5859-5863.
Walther et al., Viral Vector for Gene Transfer, Aug. 2000, Drugs, vol. 60, No. 2, pp. 249-271.
Breitburd et al., Human papillomavirus vaccines, 1999, Cancer Biology, vol. 9, pp. 431-445.
Howard et al., Nucleic Acid Vaccine Against Hepatitis Virus, 1998, Modulation of the Immune Response to Vaccine Antigens, vol. 92, pp. 157-162.
Moldoveanu et al., “Immune Responses Induced by Administration of Encapsidated Poliovirus Replicons which Express HIV-1gagand Envelope Proteins”Vaccine 13(11) :1013-1022, 1995.
Dilloo et al., “Combined Chemokine and Cytokine Gene Transfer Enhances Antitumor Immunity”Nature Medicine 2(10) :1090-1095, Oct., 1996.
Khudyakov et al., “Linear B-Cell Epitopes of the NS3-NS4-NS5 Proteins of the Hepatitis C Virus as Modeled with Synthetic Peptides”Virology 206:666-672, 1995.
Chiron Corporation
Harbin Alisa A.
Li Q. Janice
Moran Michael J.
Pasternak Dahna S.
LandOfFree
Enhancing immune responses to genetic immunization by using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhancing immune responses to genetic immunization by using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhancing immune responses to genetic immunization by using... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3415790